CGI Inc. (GIB) Q1 2026 earnings review
Cash Generation Surges, But Organic Growth Stalls
CGI kicked off Fiscal 2026 with a mixed performance. While headline revenue grew 7.7% YoY to $4.08B, the quality of that growth is questionable: Constant Currency (CC) growth was only 3.4%, likely lagging the contribution from aggressive FY25 acquisitions (BJSS, etc.), implying flat or negative organic growth. However, operational efficiency was stellar. Cash from operations surged 35% YoY to $872M (21.4% of revenue), and the company continued its shareholder return spree with $576M in buybacks. Adjusted EPS rose 7.6% to $2.12, driven largely by capital allocation rather than core business expansion.
🐂 Bull Case
Cash provided by operating activities hit $872M, a massive 21.4% of revenue (up from 17.1% a year ago). This demonstrates rigorous working capital management and supports the company's ability to self-fund its aggressive M&A and buyback strategy ($576M bought back in Q1 alone).
Driven by the integration of BJSS, the U.K. and Australia segment revenue surged 34% YoY ($566M vs $421M). This diversifies the revenue mix and reduces reliance on slower-growth regions like Canada.
🐻 Bear Case
Constant currency growth decelerated to 3.4% from 5.5% in the prior quarter. Given the significant acquisitions closed in FY25 (BJSS, Daugherty, etc.), this low figure suggests the legacy organic business is likely contracting, particularly in Western Europe.
Adjusted EBIT margin compressed 10 basis points YoY to 16.1%. While minor, this occurred despite cost-cutting measures, indicating that lower-margin acquisitions and softer pricing power are weighing on profitability.
⚖️ Verdict: ⚪
Neutral. The cash flow story is undeniable, and the balance sheet remains robust. However, the heavy reliance on M&A to mask flat/negative organic growth justifies caution. Investors should watch if the 'Build' part of the 'Build and Buy' strategy can reignite.
Key Themes
Leverage Creep from M&A Spree
The 'Buy' strategy has materially altered the balance sheet. Net debt more than doubled YoY from $1.57B to $3.45B, and the net debt-to-capitalization ratio spiked from 13.7% to 25.7%. While still healthy, the company has burned through significant dry powder, with ROIC falling 290 bps to 13.3% as capital was deployed into acquisitions that are still being integrated.
Managed Services Momentum
In a tough macro environment, clients are prioritizing cost savings, playing into CGI's strength. Managed services bookings showed a book-to-bill of 117%, signaling strong demand for outsourcing. Management noted this area is driving wins, contrasting with weaker discretionary consulting spend.
M&A Integration: UK & Australia
Accelerating. The U.K. and Australia segment has become a growth engine, with revenue jumping from $421M in 25Q1 to $566M in 26Q1. This shift reduces geographic concentration risks associated with North American markets and validates the recent BJSS acquisition strategy.
Western Europe Weakness
Decelerating. Western and Southern Europe revenue grew only ~4% ($653M to $681M) despite currency tailwinds, and margins in Germany remain pressured (12.6% vs 11.9% last year, but note volatility). The region remains a drag on overall organic growth performance compared to the Anglo-Saxon markets.
Aggressive Share Repurchases
CGI deployed $576.6 million in Q1 alone to repurchase and cancel shares, a significant acceleration compared to $152.9 million in the prior year period. This aggressive capital return is supporting EPS growth (+7.6%) significantly more than net income growth (+2.7%).
Cost of Debt Rising
Net finance costs surged to $29.1M in Q1, up over 300% from $6.6M a year ago. This reflects the increased debt load to fund FY25 acquisitions and higher interest rates. While manageable, this non-operating line item is now a measurable headwind to net earnings growth.
Other KPIs
Stable/Compressing. Down 10 basis points YoY. While U.S. Federal margin declined significantly (18.0% -> 16.2%), likely due to mix or contract timing, Western and Southern Europe margin improved (10.5% -> 13.6%), showing effective cost controls in that struggling region.
Healthy. Represents a book-to-bill ratio of 109.5%. On a trailing twelve-month basis, book-to-bill stands at 110.4%, suggesting future revenue stability despite the low current organic growth rate.
Stable. Represents 1.9x annual revenue. The sheer size of the backlog provides significant visibility and downside protection in a volatile macro environment.
Guidance
Stable. Management guided for a rate similar to the Q1 actual of 26.3%. This is consistent with previous years and offers no surprises for modeling.
Key Questions
Decomposition of Organic Growth
With Constant Currency growth at 3.4% and significant M&A contribution from BJSS and others over the last 12 months, implied organic growth appears to be flat or negative. Can you quantify the organic growth rate excluding all acquisitions closed in FY25?
U.S. Federal Margin Compression
U.S. Federal margins dropped to 16.2% from 18.0% a year ago. Is this compression structural due to contract mix (cost-plus vs fixed price) or temporary due to specific project start-up costs?
Debt Capacity and M&A Appetite
Net debt has doubled YoY to $3.45B. Given the current leverage ratio and the rising cost of debt ($29M expense this quarter), does the company plan to pause large-scale M&A to deleverage, or will the aggressive 'Buy' strategy continue in FY26?
Consulting vs. Managed Services Divergence
You noted strength in Managed Services book-to-bill (117%). Are you seeing a meaningful deterioration in discretionary SI&C (Systems Integration & Consulting) spend, particularly in the manufacturing vertical?